Allstar Health Brands, Inc.
ALST · OTC
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Valuation | ||||
| PEG Ratio | -0.00 | 0.01 | 0.00 | 0.00 |
| FCF Yield | -344.35% | -30.75% | -177.70% | -83.19% |
| EV / EBITDA | -9.00 | -32.15 | -19.53 | -2.57 |
| Quality | ||||
| ROIC | 4.07% | 3.04% | 2.86% | 3.10% |
| Gross Margin | 0.00% | 0.00% | 100.00% | 82.45% |
| Cash Conversion Ratio | 0.33 | 0.10 | 0.40 | 0.82 |
| Growth | ||||
| Revenue 3-Year CAGR | -100.00% | -100.00% | -92.83% | – |
| Free Cash Flow Growth | -830.39% | 78.91% | 6.23% | 62.61% |
| Safety | ||||
| Net Debt / EBITDA | -8.58 | -29.91 | -18.40 | -2.22 |
| Interest Coverage | -0.29 | -0.84 | -0.74 | -0.55 |
| Efficiency | ||||
| Inventory Turnover | 0.00 | 0.00 | 0.00 | 0.00 |
| Cash Conversion Cycle | 0.00 | 0.00 | 0.00 | -143,654.30 |